GILD Announces Positive Data on Trodelvy in First-Line Breast Cancer

• click to rate

  Posted by Two Blokes May 26, 2025 - Filed in Stock - 8 views
  
  Gileads Trodelvy shows significant improvement in PFS in phase III ASCENT-03 trial for first-line metastatic TNBC, reinforcing potential as backbone therapy.